1887

Journal of Medical Microbiology logo

Volume 57, Issue 5

as a risk determinant in infection Free

Abstract

The duodenal ulcer promoting () gene has been previously described as a risk marker for duodenal ulcer (DU) development and a protective factor against gastric cancer (GC). Recent studies which have assessed the application of in the prediction of clinical outcomes have been controversial. In the current study, the association of with the clinical outcomes and histopathological changes following infection was evaluated in Iranian patients. A total of 157 -infected patients with DU (=30), gastric ulcer (=23), gastritis (=68) or GC (=36) were assessed. The presence of and genes was determined by gene specific PCR. Gastric histopathological changes were recorded according to the updated Sydney system. Seventy-eight (49.7 %) and 71 (45.2 %) of the 157 tested strains, respectively, were positive and negative for both genes. The remaining 8 (5.09 %) of the 157 strains were -positive/-negative. Univariate analysis showed inverse associations between and histological features including dysplasia as the penultimate stage of GC and lymphoid follicles as a consequence of relatively long-standing -associated gastritis. The degrees of nucleotide sequence identity of Iranian strains to Colombian, Brazilian and Indian strains ranged from 86.1 to 100 % for the aligned regions of , from 88  to 98.8 % for and from 93.4  to 99.5 % for the partial sequences of the gene. Despite the fact that possession of the gene showed no association with any disease category in our population as reported in several other countries, association of -negative strains of with pre-malignant lesions calls for additional studies to evaluate the role of this gene as a protective marker against GC.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): DU, duodenal ulcer , GC, gastric cancer and GU, gastric ulcer
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47776-0
2008-05-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/5/554.html?itemId=/content/journal/jmm/10.1099/jmm.0.47776-0&mimeType=html&fmt=ahah

References

  1. Alm R. A., Trust T. J. 1999; Analysis of the genetic diversity of Helicobacter pylori : the tale of two genomes. J Mol Med 77:834–846 [CrossRef]
     [Google Scholar]
  2. Alm R. A., Ling L. S., Moir D. T., King B. L., Brown E. D., Doig P. C., Smith D. R., Noonan B., Guild B. C. other authors 1999; Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori . Nature 397:176–180 [CrossRef]
     [Google Scholar]
  3. Arachchi H. S., Kalra V., Lal B., Bhatia V., Baba C. S., Chakravarthy S., Rohatgi S., Sarma P. M., Mishra V. other authors 2007; Prevalence of duodenal ulcer-promoting gene ( dupA ) of Helicobacter pylori in patients with duodenal ulcer in north Indian population. Helicobacter 12:591–597 [CrossRef]
     [Google Scholar]
  4. Argent R. H., Kidd M., Owen R. J., Thomas R. J., Limb M. C., Atherton J. C. 2004; Determinants and consequences of different level of CagA phosphorylation for clinical isolates of Helicobacter pylori . Gastroenterology 127:514–523 [CrossRef]
     [Google Scholar]
  5. Argent R. H., Burette A., Miendje Deyi V. Y., Atherton J. C. 2007; The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin Infect Dis 45:1204–1206 [CrossRef]
     [Google Scholar]
  6. Atherton J. C., Cao P., Peek R. M. Jr, Tummuru M. K. R., Blaser M. J., Cover T. L. 1995; Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori . J Biol Chem 270:17771–17777 [CrossRef]
     [Google Scholar]
  7. Azuma T., Yamakawa A., Yamazaki S., Fukuta K., Ohtani M., Ito Y., Dojo M., Yamazaki Y., Kuriyama M. 2002; Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 186:1621–1630 [CrossRef]
     [Google Scholar]
  8. Blaser M. J. 1997; Ecology of Helicobacter pylori in the human stomach. J Clin Invest 100:759–762 [CrossRef]
     [Google Scholar]
  9. Censini S., Lange C., Xiang Z., Crabtree J. E., Ghiara P., Borodovsky M., Rappuoli R., Covacci A. 1996; cag , a pathogenicity island of Helicobacter pylori , encodes type-I specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 93:14648–14653 [CrossRef]
     [Google Scholar]
  10. Covacci A., Censini S., Bugnoli M., Petracca R., Burroni D., Macchia G., Massone A., Papini E., Xiang Z., Figura N. 1993; Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 90:5791–5795 [CrossRef]
     [Google Scholar]
  11. Crabtree J. E., Taylor J., Wyatt J. I., Heatley R. V., Shallcross T. M., Tompkins D. S., Rathbone B. J. 1991; Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332–335 [CrossRef]
     [Google Scholar]
  12. de Jonge R., Kuipers E. J., Langeveld S. C., Loffeld R. J., Stoof J., van Vliet A. H., Kusters J. G. 2004; The Helicobacter pylori plasticity region locus jhp0947-jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol Med Microbiol 41:161–167 [CrossRef]
     [Google Scholar]
  13. Figueiredo C., van Doorn L. J., Nogueira C., Soares J. M., Pinho C., Figueira P., Quint W. G., Carneiro F. 2001; Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 36:128–135 [CrossRef]
     [Google Scholar]
  14. Gerhard M., Lehn N., Neumayer N., Boren T., Rad R., Schepp W., Miehlke S., Classen M., Prinz C. 1999; Clincal relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesion. Proc Natl Acad Sci U S A 96:12778–12783 [CrossRef]
     [Google Scholar]
  15. Gomes L. I., Rocha G. A., Rocha A. M. C., Soares T. F., Oliveira C. A., Bittencourt P. F. S., Queiroz D. M. M. 2007; Lack of association between Helicobacter pylori infection with dupA -positive strains and gastroduodenal diseases in Brazilian patients. Int J Med Microbiol in press
    [Google Scholar]
  16. Graham D. Y. 1989; Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:Suppl.615–625
     [Google Scholar]
  17. Labigne A., Cussac V., Courcoux P. 1991; Shuttle cloning and nucleotide sequencing of Helicobacter genes responsible for urease activity. J Bacteriol 173:1920–1931
     [Google Scholar]
  18. Lu H., Hsu P.-I., Graham D. Y., Yamaoka Y. 2005; Duodenal ulcer promoting gene of Helicobacter pylori . Gastroenterology 128:833–848 [CrossRef]
     [Google Scholar]
  19. McColl K. E., El-Omar E., Gillen D. 2000; Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 29:687–703 [CrossRef]
     [Google Scholar]
  20. Miehlke S., Kirsch C., Agha-Amiri K., Günther T., Lehn N., Malfertheiner P., Stolte M., Ehninger G., Bayerdörffer E. 2000; The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 87:322–327 [CrossRef]
     [Google Scholar]
  21. Occhialini A., Marais A., Alm R., Garcia F., Sierra R., Megraud F. 2000; Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun 68:6240–6249 [CrossRef]
     [Google Scholar]
  22. Parsonnet J., Friedman G. D., Orentreich N., Vogelman H. 1997; Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297–301 [CrossRef]
     [Google Scholar]
  23. Prinz C., Schoniger M., Rad R., Becker I., Keiditsch E., Wagenpfeil S., Classen M., Rosch T., Schepp W., Gerhard M. 2001; Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 61:1903–1909
     [Google Scholar]
  24. Santos A., Queiroz D. M., Menard A., Marais A., Rocha G. A., Oliveira C. A., Nogueira A. M., Uzeda M., Megraud F. 2003; New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J Clin Microbiol 41:1651–1655 [CrossRef]
     [Google Scholar]
  25. Sipponen P., Stolte M. 1997; Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 29:671–678 [CrossRef]
     [Google Scholar]
  26. Talebkhan Y., Mohammadi M., Mohagheghi M. A., Vaziri H. R., Eshagh Hosseini M., Mohajerani N., Oghalaei A., Esmaeili M., Zamaninia L. 2007; cagA gene and protein status among Iranian Helicobacter pylori strains. Dig Dis Sci in press
    [Google Scholar]
  27. Tomb J. F., White O., Kerlavage A. R., Clayton R. A., Sutton G. G., Fleischmann R. D., Ketchum K. A., Klenk H. P., Gill S. other authors 1997; The complete genome sequence of the gastric pathogen Helicobacter pylori . Nature 388:539–547 [CrossRef]
     [Google Scholar]
  28. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R. J. 2001; Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789 [CrossRef]
     [Google Scholar]
  29. Weel J. F., van der Hulst R. W., Gerrits Y., Roorda P., Feller M., Dankert J., Tytgat G. N., van der Ende A. 1996; The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori -related diseases. J Infect Dis 173:1171–1175 [CrossRef]
     [Google Scholar]
  30. Yamaoka Y., El-Zimaity H. M. T., Gutierrez O., Figura N., Kim J. K., Kodama K., Kashima K., Graham D. Y. 1999; Relationship between the cagA 3′ repeat region of Helicobacter pylori , gastric histology, and susceptibility to low pH. Gastroenterology 117:342–349 [CrossRef]
     [Google Scholar]
  31. Yamaoka Y., Kwon D. H., Graham D. Y. 2000; A Mr 34,000 proinflammatory outer membrane protein ( oipA ) of Helicobacter pylori . Proc Natl Acad Sci U S A 97:7533–7538 [CrossRef]
     [Google Scholar]
  32. Yamaoka Y., Kikuchi S., El-Zimaity H. M. T., Gutierrez O., Osato M. S., Graham D. Y. 2002; Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin-8 production. Gastroenterology 123:414–424 [CrossRef]
     [Google Scholar]
  33. Yu J., Leung W. K., Go M. Y. Y., Chan M. C. W., To K. F., Ng E. K., Chan F. K., Ling T. K., Chung S. C., Sung J. J. 2002; Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 51:480–484 [CrossRef]
     [Google Scholar]
  34. Zambon C. F., Navaglia F., Basso D., Rugge M., Plebani M. 2003; Helicobacter pylori babA2 , cagA , and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 56:287–291 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47776-0
Loading
dupA as a risk determinant in Helicobacter pylori infection
J. Med. Microbiol. 57, 554 (2008); https://doi.org/10.1099/jmm.0.47776-0
/content/journal/jmm/10.1099/jmm.0.47776-0
/content/journal/jmm/10.1099/jmm.0.47776-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error